• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雾化吸入非诺特罗与静脉注射氨茶碱治疗急性重症哮喘

Nebulized fenoterol and i.v. aminophylline in acute severe asthma.

作者信息

Bowler S D, Mitchell C A, Armstrong J G, Scicchitano R

出版信息

Eur J Respir Dis. 1987 May;70(5):280-3.

PMID:3609188
Abstract

We investigated the bronchodilator effect of intravenous aminophylline given after a cumulative dose of nebulized fenoterol of 2.4 mg in 18 patients with acute severe asthma. The mean forced expiratory volume in 1 s (FEV1) +/- SD before treatment was 0.72 +/- 0.22 l. The mean improvement in FEV1 after fenoterol was 0.64 +/- 0.39 l (85% of total improvement) and after aminophylline 0.11 +/- 0.13 l (15% of total improvement). The improvement after aminophylline was statistically significant (p less than 0.01), though quantitatively small. Thirteen patients improved after aminophylline by less than 0.15 l, and in only five was the improvement 0.2-0.4 l. There was no significant change in heart rate and subjective tremor score with treatment, although observed tremor (0 = absent, 4 = maximum) increased from 0.4 +/- 0.6 to 1.3 +/- 1.0 after all treatment. For the majority of patients presenting with acute severe asthma, it is likely that high doses of nebulized beta-2 agonist alone will produce near maximal bronchodilation in the short term.

摘要

我们研究了18例急性重症哮喘患者在雾化吸入累计剂量为2.4mg非诺特罗后静脉注射氨茶碱的支气管扩张作用。治疗前1秒用力呼气容积(FEV1)的平均值±标准差为0.72±0.22升。非诺特罗治疗后FEV1的平均改善值为0.64±0.39升(占总改善值的85%),氨茶碱治疗后为0.11±0.13升(占总改善值的15%)。氨茶碱治疗后的改善具有统计学意义(p<0.01),尽管在量上较小。13例患者在使用氨茶碱后改善值小于0.15升,只有5例患者的改善值为0.2 - 0.4升。治疗过程中心率和主观震颤评分无显著变化,尽管观察到的震颤(0 = 无,4 = 最大)在所有治疗后从0.4±0.6增加到1.3±1.0。对于大多数急性重症哮喘患者,短期内单独使用高剂量雾化β2激动剂可能会产生接近最大程度的支气管扩张。

相似文献

1
Nebulized fenoterol and i.v. aminophylline in acute severe asthma.雾化吸入非诺特罗与静脉注射氨茶碱治疗急性重症哮喘
Eur J Respir Dis. 1987 May;70(5):280-3.
2
Nebulized fenoterol in severe asthma: determinants of the dose response.严重哮喘中雾化吸入非诺特罗:剂量反应的决定因素
Eur J Respir Dis. 1983 Jul;64(5):340-6.
3
Bronchodilator effects of a fenoterol metered dose inhaler and fenoterol powder in asthmatics with poor inhaler technique.非诺特罗定量气雾剂和非诺特罗粉雾剂对吸入技术不佳的哮喘患者的支气管扩张作用。
Eur J Respir Dis. 1986 May;68(5):332-5.
4
[Current approach to the treatment of acute bronchial asthma].
Ter Arkh. 2000;72(8):10-2.
5
Aminophylline, salbutamol and combined intravenous infusions in acute severe asthma.氨茶碱、沙丁胺醇及联合静脉输注治疗急性重症哮喘
Br J Dis Chest. 1980 Oct;74(4):385-9.
6
Nebulized fenoterol versus i.v. aminophylline treatment of acute severe asthma.雾化吸入非诺特罗与静脉注射氨茶碱治疗急性重症哮喘的比较
Am J Emerg Med. 1995 Nov;13(6):677-80. doi: 10.1016/0735-6757(95)90066-7.
7
[Treatment of severe bronchial asthma and status asthmaticus with intravenous fenoterol].[静脉注射非诺特罗治疗重度支气管哮喘和哮喘持续状态]
Dtsch Med Wochenschr. 1988 May 13;113(19):763-6. doi: 10.1055/s-2008-1067717.
8
Bronchial responsiveness during regular fenoterol therapy: four months prospective study.常规使用非诺特罗治疗期间的支气管反应性:四个月的前瞻性研究。
N Z Med J. 1991 Jan 23;104(904):3-5.
9
Combined anticholinergic therapy in the management of acute asthma.联合抗胆碱能疗法在急性哮喘管理中的应用
Respirology. 1997;2 Suppl 1:S17-8.
10
Comparison of a single dose of aerosol salbutamol and fenoterol/ipratropium on bronchial asthmatic patients.
Del Med J. 1994 Oct;66(10):549-52.

引用本文的文献

1
Theophylline.茶碱
Pharmaceuticals (Basel). 2010 Mar 18;3(3):725-747. doi: 10.3390/ph3030725.